New Deal
Mark McDade
Managing Partner at QIMING VENTURE PARTNERS
Investor
Deal Bio
Expertise (14)
Key Relationships
Sort
Cadent Therapeutics
Novartis
£576m
6 dealmakers
Nice Tuan
Cygnus Equity
£322m
29 dealmakers
YUANBAO
Susquehanna International Group
£111m
7 dealmakers
LETSGETCHECKED
Transformation Capital Partners
£105m
12 dealmakers
Insilico Medicine
Formica Capital
£183m
18 dealmakers
Yuanxin Technology
Citic Securities Co
£166m
13 dealmakers
SHOUTI
Casdin Capital
£72m
20 dealmakers
Abogen Biosciences
Invesco Asset Management
£520m
28 dealmakers
Korro Bio
Atlas Venture
£85m
14 dealmakers
Zhenge Biotech
Lyfe Capital
£73m
9 dealmakers
MAFENGWO
Tencent Holdings
£220m
5 dealmakers
TUNGEE
Hongshan (former Sequoia Capital China)
£15m
3 dealmakers
TUHU
Welkin Capital
£400m
8 dealmakers
DEEPWAY
Sb China Venture Capital (sbcvc)
£90m
Boost your presence by claiming deals. Enhance your profile, highlighting your industry impact.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.